Home Cart 0 Sign in  

[ CAS No. 764-85-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 764-85-2
Chemical Structure| 764-85-2
Structure of 764-85-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 764-85-2 ]

Related Doc. of [ 764-85-2 ]

Alternatived Products of [ 764-85-2 ]

Product Details of [ 764-85-2 ]

CAS No. :764-85-2 MDL No. :MFCD00000768
Formula : C9H17ClO Boiling Point : -
Linear Structure Formula :- InChI Key :NTQYXUJLILNTFH-UHFFFAOYSA-N
M.W : 176.68 Pubchem ID :69819
Synonyms :
Chemical Name :Nonanoylchloride

Calculated chemistry of [ 764-85-2 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.89
Num. rotatable bonds : 7
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 50.37
TPSA : 17.07 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.25 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.83
Log Po/w (XLOGP3) : 4.4
Log Po/w (WLOGP) : 3.5
Log Po/w (MLOGP) : 2.7
Log Po/w (SILICOS-IT) : 3.32
Consensus Log Po/w : 3.35

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.25
Solubility : 0.1 mg/ml ; 0.000568 mol/l
Class : Soluble
Log S (Ali) : -4.48
Solubility : 0.00591 mg/ml ; 0.0000335 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -3.66
Solubility : 0.0384 mg/ml ; 0.000217 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 2.1

Safety of [ 764-85-2 ]

Signal Word:Danger Class:8
Precautionary Statements:P261-P271-P280-P303+P361+P353-P304+P340+P310-P305+P351+P338 UN#:3265
Hazard Statements:H314-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 764-85-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 764-85-2 ]
  • Downstream synthetic route of [ 764-85-2 ]

[ 764-85-2 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 764-85-2 ]
  • [ 123-29-5 ]
Reference: [1] Tetrahedron Letters, 1980, vol. 21, p. 3147 - 3150
  • 2
  • [ 764-85-2 ]
  • [ 64-17-5 ]
  • [ 123-29-5 ]
Reference: [1] Chinese Journal of Chemistry, 2011, vol. 29, # 10, p. 2153 - 2156
  • 3
  • [ 764-85-2 ]
  • [ 1196-92-5 ]
  • [ 2444-46-4 ]
YieldReaction ConditionsOperation in experiment
88.6% With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; To a solution of the hydrochloride or hydrobromide salt of an amine (1 mmol) in anhydrous N,N- dimethylformamide (DMF) (2 mL) was added N, N- diisopropylethylamine (DIPEA) (2 mmol) to liberate the amine. After stirring at room temperature for 10 min, nonanoyl chloride (1 mmol) was added. The solution was stirred at room temperature for 6 to 24 h. After the reaction, water (40 mL) was added to the solution. The reaction mixture was transferred to a separating funnel and extracted with dichloromethane, CH2Cl2 (3 * 6 mL) . The organic extracts were concentrated under reduced pressure to give a crude product. The crude product was then purified by silica gel column chromatography (using hexane/ethyl acetate, 2:1 v/v, as eluent) or preparative HPLC (using the protocol set out in "Analytical Protocols" above) to give the final product.
Reference: [1] Advanced Synthesis and Catalysis, 2014, vol. 356, # 9, p. 2113 - 2118
[2] Patent: WO2010/144055, 2010, A1, . Location in patent: Page/Page column 45-46; 50
[3] Journal of Medicinal Chemistry, 1993, vol. 36, # 18, p. 2595 - 2604
[4] Recueil des Travaux Chimiques des Pays-Bas, 1934, vol. 53, p. 855
[5] Journal of the American Chemical Society, 1919, vol. 41, p. 2121[6] Journal of the American Chemical Society, 1920, vol. 42, p. 597
[7] Journal of Medicinal Chemistry, 1993, vol. 36, # 16, p. 2362 - 2372
  • 4
  • [ 764-85-2 ]
  • [ 7149-10-2 ]
  • [ 2444-46-4 ]
YieldReaction ConditionsOperation in experiment
91.5% With sodium hydrogencarbonate In dichloromethane; water at 20 - 42℃; for 2.5 h; 1) Preparation of crude product mixture: 105 g of vanillinamine hydrochloride was added to a mixture consisting of 200 g of sodium hydrogencarbonate, 500 mL of dichloromethane and 600 mL of water, and the mixture was stirred well and the mixture was further heated at room temperature (Methylene chloride: volume: 146.4 mL) was added dropwise over 1 hour. After completion of the dropwise addition, the temperature was raised to 42 ° C and maintained at that temperature for 1.5 hours. To obtain a crude product mixture (1420 mL);(2) Crystallization purification: The crude product mixture was cooled to room temperature, first using 200 mL of 25percentHydrochloric acid solution was shaken and allowed to stand for separation. The organic phase was separated (about 750 mL), and 150 mL of a 20percentOf the sodium hydroxide solution was shaken and the organic phase was washed and allowed to stand for separation. The organic phase was separated again750 mL), washed with 200 mL of water, and partitioned. After washing with water, the organic phase (about 750 mL)150 mL of methylene chloride was distilled off to give a concentrated organic phase (ca. 600 mL), which was added to the concentrated organic phase1080mL petroleum ether after cooling crystallization, cooling rate of 0.25 / min, crystallization termination temperature of aboutAt -10 & lt; 0 & gt; C, maintaining the crystallization termination temperature for at least 30 min, filtering at the crystallization termination temperature,Dried to obtain solid synthetic capsaicin 148.6g, the yield was 91.5percent, by high performance liquid chromatography(HPLC) to determine the purity of 99.5percent.
Reference: [1] Patent: , 2016, , . Location in patent: Paragraph 0040; 0041; 0042
[2] Journal of Agricultural and Food Chemistry, 2010, vol. 58, # 6, p. 3342 - 3349
  • 5
  • [ 764-85-2 ]
  • [ 2444-46-4 ]
Reference: [1] Annales pharmaceutiques françaises, 1959, vol. 17, p. 453 - 455
Same Skeleton Products
Historical Records